Trial Profile
A single blind, placebo controlled, crossover study investigating safety and pharmacokinetics of Eluxadoline in healthy volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 02 May 2018
Price :
$35
*
At a glance
- Drugs Eluxadoline (Primary)
- Indications Irritable bowel syndrome
- Focus Pharmacodynamics
- 22 Apr 2016 New trial record
- 12 Mar 2016 Results presented at the 117th Annual Meeting of the American Society for Clinical Pharmacology and Therapeutics.